Differences in Clinical and Biological Features Between Type I and Type II Tumors in FIGO Stages I-II Epithelial Ovarian Carcinoma

Por Skirnisdottir, Ingiridur, Seidal, Tomas, Åkerud, Helena
Publicado no Int J Gynecol Cancer (2015)

The relationship of the angiogenesis regulators VEGF-A, VEGF-R1 and VEGF-R2 to p53 status and prognostic factors in epithelial ovarian carcinoma in FIGO-stages I–II

Por SKIRNISDOTTIR, INGIRIDUR, SEIDAL, TOMAS, ÅKERUD, HELENA
Publicado no Int J Oncol (2016)

Napsin A as a marker of clear cell ovarian carcinoma

Por Skirnisdottir, Ingiridur, Bjersand, Kathrine, Åkerud, Helena, Seidal, Tomas
Publicado no BMC Cancer (2013)

Binding of TS1, an anti-keratin 8 antibody, in small-cell lung cancer after (177)Lu-DOTA-Tyr(3)-octreotate treatment: a histological study in xenografted mice

Por Erlandsson, Ann, Forssell-Aronsson, Eva, Seidal, Tomas, Bernhardt, Peter
Publicado em 2011

Type 1 plasminogen activator inhibitor (PAI-1) in clear cell renal cell carcinoma (CCRCC) and its impact on angiogenesis, progression and patient survival after radical nephrectomy

Por Zubac, Dragomir P, Wentzel-Larsen, Tore, Seidal, Tomas, Bostad, Leif
Publicado em 2010

The clinical and prognostic correlation of HRNPM and SLC1A5 in pathogenesis and prognosis in epithelial ovarian cancer

Por Bjersand, Kathrine, Seidal, Tomas, Sundström-Poromaa, Inger, Åkerud, Helena, Skirnisdottir, Ingiridur
Publicado no PLoS One (2017)

The prognostic relevance of interactions between venous invasion, lymph node involvement and distant metastases in renal cell carcinoma after radical nephrectomy

Por Zubac, Dragomir P, Bostad, Leif, Seidal, Tomas, Wentzel-Larsen, Tore, Haukaas, Svein A
Publicado em 2008